Moleculin Biotech Inc - ESG Rating & Company Profile powered by AI
If you work at Moleculin Biotech Inc and you wish to use your ESG aseessment, please contact us. The report of Moleculin Biotech Inc leverages data points from across the internet as well as from public documents by Moleculin Biotech Inc. This webpage of Moleculin Biotech Inc was assembled by All Street Sevva using leading NLP.
Moleculin Biotech Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Moleculin Biotech Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Moleculin Biotech Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Moleculin Biotech Inc report the average age of the workforce?
Sign up for free to unlockDoes Moleculin Biotech Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Moleculin Biotech Inc offer flexible work?
Sign up for free to unlockDoes Moleculin Biotech Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Moleculin Biotech Inc conduct supply chain audits?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Moleculin Biotech Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose water use targets?
Sign up for free to unlockDoes Moleculin Biotech Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Moleculin Biotech Inc have a product recall in the last two years?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Moleculin Biotech Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Moleculin Biotech Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose parental leave metrics?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Moleculin Biotech Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Moleculin Biotech Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Moleculin Biotech Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose its waste policy?
Sign up for free to unlockDoes Moleculin Biotech Inc report according to TCFD requirements?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose energy use targets?
Sign up for free to unlockDoes Moleculin Biotech Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Moleculin Biotech Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Moleculin Biotech Inc
These potential risks are based on the size, segment and geographies of the company.
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial for the treatment of brain tumors and pediatric brain tumors, as well as pancreatic cancer and other malignancies. It also develops WP1220, an analog of WP1066 for the topical treatment of cutaneous T-cell lymphoma; and WP1122 to treat glioblastoma multiforme and COVID-19. The company has partnership and collaboration agreements with MD Anderson; Animal Life Sciences, LLC; and WPD Pharmaceuticals Sp z.o.o. Moleculin Biotech, Inc. was incorporated in 2015 and is headquartered in Houston, Texas.